Stratos Wealth Partners LTD. Has $1.05 Million Stake in The Cooper Companies, Inc. $COO

Stratos Wealth Partners LTD. trimmed its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 2.7% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 14,757 shares of the medical device company’s stock after selling 408 shares during the quarter. Stratos Wealth Partners LTD.’s holdings in Cooper Companies were worth $1,050,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of COO. Goldman Sachs Group Inc. raised its position in shares of Cooper Companies by 17.0% during the first quarter. Goldman Sachs Group Inc. now owns 4,734,327 shares of the medical device company’s stock worth $399,340,000 after purchasing an additional 686,751 shares during the period. Millennium Management LLC raised its position in shares of Cooper Companies by 36.0% during the first quarter. Millennium Management LLC now owns 2,577,416 shares of the medical device company’s stock worth $217,405,000 after purchasing an additional 682,166 shares during the period. Nuveen LLC acquired a new position in shares of Cooper Companies during the first quarter worth approximately $55,367,000. Alecta Tjanstepension Omsesidigt raised its position in shares of Cooper Companies by 60.7% during the second quarter. Alecta Tjanstepension Omsesidigt now owns 1,349,500 shares of the medical device company’s stock worth $96,030,000 after purchasing an additional 509,800 shares during the period. Finally, Select Equity Group L.P. raised its position in shares of Cooper Companies by 185.0% during the first quarter. Select Equity Group L.P. now owns 749,050 shares of the medical device company’s stock worth $63,182,000 after purchasing an additional 486,241 shares during the period. 24.39% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other news, CEO Albert G. White III purchased 10,000 shares of the company’s stock in a transaction dated Friday, September 5th. The shares were purchased at an average price of $68.39 per share, with a total value of $683,900.00. Following the transaction, the chief executive officer directly owned 226,151 shares of the company’s stock, valued at approximately $15,466,466.89. This represents a 4.63% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, COO Gerard H. Warner III purchased 1,450 shares of the company’s stock in a transaction dated Friday, September 5th. The shares were purchased at an average cost of $69.23 per share, for a total transaction of $100,383.50. Following the transaction, the chief operating officer directly owned 18,319 shares in the company, valued at approximately $1,268,224.37. The trade was a 8.60% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last three months, insiders have bought 17,975 shares of company stock worth $1,216,346. 1.98% of the stock is owned by company insiders.

Cooper Companies Stock Up 0.0%

Shares of NASDAQ:COO opened at $75.00 on Wednesday. The company has a market capitalization of $14.91 billion, a PE ratio of 36.95, a price-to-earnings-growth ratio of 1.97 and a beta of 1.02. The company has a debt-to-equity ratio of 0.29, a current ratio of 2.12 and a quick ratio of 1.24. The business has a fifty day moving average price of $69.64 and a two-hundred day moving average price of $73.21. The Cooper Companies, Inc. has a 1 year low of $61.78 and a 1 year high of $109.04.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings data on Wednesday, August 27th. The medical device company reported $1.10 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.07 by $0.03. The firm had revenue of $1.06 billion during the quarter, compared to the consensus estimate of $1.06 billion. Cooper Companies had a return on equity of 9.82% and a net margin of 10.08%.The business’s revenue for the quarter was up 5.7% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.96 EPS. Cooper Companies has set its Q4 2025 guidance at 1.100-1.140 EPS. FY 2025 guidance at 4.080-4.120 EPS. Analysts forecast that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Cooper Companies declared that its Board of Directors has approved a share repurchase plan on Wednesday, September 17th that permits the company to buyback $2.00 billion in outstanding shares. This buyback authorization permits the medical device company to reacquire up to 15.4% of its shares through open market purchases. Shares buyback plans are often a sign that the company’s board of directors believes its shares are undervalued.

Analyst Ratings Changes

Several brokerages recently issued reports on COO. BNP Paribas Exane upgraded Cooper Companies from a “neutral” rating to an “outperform” rating and set a $92.00 price target for the company in a report on Tuesday, July 22nd. Piper Sandler decreased their price target on Cooper Companies from $105.00 to $83.00 and set an “overweight” rating for the company in a report on Thursday, August 28th. Robert W. Baird decreased their price target on Cooper Companies from $97.00 to $85.00 and set an “outperform” rating for the company in a report on Thursday, August 28th. BNP Paribas upgraded Cooper Companies from a “hold” rating to a “strong-buy” rating in a report on Tuesday, July 22nd. Finally, Wall Street Zen downgraded Cooper Companies from a “buy” rating to a “hold” rating in a report on Saturday, July 12th. One equities research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating, three have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, Cooper Companies presently has a consensus rating of “Moderate Buy” and a consensus price target of $84.77.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.